Back to Search
JEFFREY QUINN, M.D.
M.D.
Neurology Physician
NPI: 1922455872IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
01093374A(IN)A168961(CA)
CMS Specialties
PrimaryNEUROLOGY
Education
LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Class of 2016
Research & Publications (20)
Dorsal hippocampus involvement in delay fear conditioning depends upon the strength of the tone-footshock association.
PMID 18306286·Hippocampus·2008
7-preclinical
Inverse temporal contributions of the dorsal hippocampus and medial prefrontal cortex to the expression of long-term fear memories.
PMID 18441294·Learn Mem·2008
7-preclinical
Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning.
PMID 15959918·Hippocampus·2005
7-preclinical
Copper response element and Crr1-dependent Ni(2+)-responsive promoter for induced, reversible gene expression in Chlamydomonas reinhardtii.
PMID 14555481·Eukaryot Cell·2003
7-preclinical
Oxygen deficiency responsive gene expression in Chlamydomonas reinhardtii through a copper-sensing signal transduction pathway.
PMID 11842150·Plant Physiol·2002
7-preclinical
Post-training excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and delay fear conditioning in a temporally specific manner.
PMID 12201634·Hippocampus·2002
7-preclinical
Coordinate copper- and oxygen-responsive Cyc6 and Cpx1 expression in Chlamydomonas is mediated by the same element.
PMID 10692397·J Biol Chem·2000
7-preclinical
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
PMID 19204199·J Clin Oncol·2009
3-trial
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
PMID 19289491·Neuro Oncol·2009
3-trial
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Copper in Alzheimer's disease: too much or too little?
PMID 19402774·Expert Rev Neurother·2009
6-review
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Yield of diagnostic tests in evaluating syncopal episodes in older patients--invited commentary.
PMID 19636032·Arch Intern Med·2009
8-other
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.
PMID 19188181·Clin Cancer Res·2009
3-trial
Parameter and state estimation of experimental chaotic systems using synchronization.
PMID 19658786·Phys Rev E Stat Nonlin Soft Matter Phys·2009
8-other
BRCA1 and implications for response to chemotherapy in ovarian cancer.
PMID 19168207·Gynecol Oncol·2009
6-review
Regulation of activity-dependent neuroprotective protein (ADNP) by the NO-cGMP pathway in the hippocampus during kainic acid-induced seizure.
PMID 18375135·Neurobiol Dis·2008
4-observational
Death after emergency department visits for syncope: how common and can it be predicted?
PMID 17889403·Ann Emerg Med·2008
8-other
New ways to break an old bond: the bacterial carbon-phosphorus hydrolases and their role in biogeochemical phosphorus cycling.
PMID 17803765·Environ Microbiol·2007
6-review
BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy.
PMID 18094425·Clin Cancer Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 1653 W CONGRESS PKWY
CHICAGO, IL 60612 - Phone
- (312) 942-5000
Locations (4)
Quick Facts
- NPI
- 1922455872
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 4
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile